The multiple sclerosis monitoring study: Progress to date

The multiple sclerosis monitoring study: Progress to date

Podrobná bibliografie
Hlavní autoři:	Cooper, C, Palace, J, Pickin, M, Boggild, M, Nichol, J, Consortium, MS
Médium:	Conference item
Vydáno:	2004

Podobné jednotky

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future
Autor: Pickin, M, a další
Vydáno: (2009)

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.
Autor: Pickin, M, a další
Vydáno: (2009)

The UK Multiple Sclerosis database.
Autor: Palace, J, a další
Vydáno: (1999)

Modifying disability in progressive multiple sclerosis.
Autor: Palace, J, a další
Vydáno: (2014)

Modifying disability in progressive multiple sclerosis
Autor: Palace, J, a další
Vydáno: (2014)

EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Autor: Arun, T, a další
Vydáno: (2009)

The UK long-term cost-effectiveness study of disease-modifying therapies in multiple sclerosis: lessons from tire first analysis
Autor: Palace, J, a další
Vydáno: (2008)

Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex
Autor: Yates, R, a další
Vydáno: (2017)

Modelling natural history for the UK multiple sclerosis risk-sharing scheme
Autor: Palace, J, a další
Vydáno: (2013)

Making the diagnosis of multiple sclerosis.
Autor: Palace, J
Vydáno: (2001)

Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.
Autor: Boggild, M, a další
Vydáno: (2009)

New and old treatments for multiple sclerosis.
Autor: Palace, J
Vydáno: (1998)

Progress in deciphering the genetics of multiple sclerosis.
Autor: Herrera, B, a další
Vydáno: (2003)

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
Autor: Kremenchutzky, M, a další
Vydáno: (1999)

The natural history of multiple sclerosis: a geographically based study 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation
Autor: Kremenchutzky, M, a další
Vydáno: (1999)

Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
Autor: Noseworthy, J, a další
Vydáno: (1989)

UK multiple sclerosis risksharing scheme: A new natural history dataset and an improved Markov model
Autor: Palace, J, a další
Vydáno: (2014)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
Autor: Wakerley, B, a další
Vydáno: (2011)

Guidelines for differential diagnosis of suspected multiple sclerosis.
Autor: Palace, J
Vydáno: (2009)

ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride
Autor: Arun, T, a další
Vydáno: (2013)

New treatments and azathioprine in multiple sclerosis.
Autor: Palace, J, a další
Vydáno: (1997)

AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Autor: Arun, T, a další
Vydáno: (2012)

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
Autor: Noseworthy, J
Vydáno: (1991)

Modelling progressive multiple sclerosis for new treatment strategies
Autor: Roodselaar, J
Vydáno: (2019)

Thalamic neurodegeneration in multiple sclerosis.
Autor: Cifelli, A, a další
Vydáno: (2002)

Natural history of primary progressive multiple sclerosis.
Autor: Ebers, G
Vydáno: (2004)

Natural history of primary progressive multiple sclerosis
Autor: Ebers, G
Vydáno: (2004)

Interleukin-17 expression in multiple sclerosis
Autor: Tzartos, J, a další
Vydáno: (2006)

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
Autor: Arun, T, a další
Vydáno: (2013)

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Autor: Arun, T, a další
Vydáno: (2013)

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Autor: Palace, J
Vydáno: (2009)

Primary progressive multiple sclerosis: Brain MRI findings
Autor: Kremenchutzky, M, a další
Vydáno: (1999)

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
Autor: Parry, A, a další
Vydáno: (2003)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
Autor: Parry, A, a další
Vydáno: (2002)

COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Autor: Matthews, L, a další
Vydáno: (2010)

UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
Autor: Palace, J, a další
Vydáno: (2014)

DIRECT COMPARISON OF MULTIPLE NONLESIONAL IMAGING MEASURES TO ASSESS THEIR POWER TO MEASURE TREATMENT EFFECTS OVER 1 YEAR IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Autor: Arun, T, a další
Vydáno: (2010)

Treatment of active secondary progressive multiple sclerosis with treosulfan.
Autor: Wiendl, H, a další
Vydáno: (2007)

Modafinil for multiple sclerosis fatigue: does it work?
Autor: Littleton, E, a další
Vydáno: (2010)

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
Autor: Cottrell, D, a další
Vydáno: (1999)